Used in biomedical research to quantify Angiopoietin-like Protein 3 (ANGPTL3) levels in biological samples such as serum, plasma, and cell culture supernatants. This ELISA kit enables researchers to study the role of ANGPTL3 in lipid metabolism, insulin sensitivity, and cardiovascular diseases. It is widely applied in studies related to atherosclerosis, hyperlipidemia, and metabolic syndrome. The assay supports high-throughput screening in drug development, particularly for therapies targeting lipid regulation and novel anti-dyslipidemia agents. Due to ANGPTL3’s involvement in inhibiting lipoprotein lipase and endothelial lipase, this kit is essential for investigating new treatments that modulate these pathways. Results are reliable and reproducible, making it suitable for both academic and pharmaceutical research settings.